Review

cd69 pe cy5 (Revvity)

Revvity is a verified supplier

Revvity manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Revvity cd69 pe cy5
Cd69 Pe Cy5, supplied by Revvity, used in various techniques. Bioz Stars score: 99/100, based on 850 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd69 pe cy5/product/Revvity
Average 99 stars, based on 850 article reviews

cd69 pe cy5 - by Bioz Stars, 2026-03

99/100 stars

Images

Image Search Results

Frequency of MAIT cells after 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (A). Comparison of frequency of CD69+, CD25+, LAG-3+, PD-1+, and TIM-3+ MAIT cells after 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (B-F). Gating strategy and frequency of TNF-α+ and IFN-γ+ MAIT cells following 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (G-I). Frequency of Granzyme-B+ MAIT cells after 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (J). Comparison of MFI of T-bet expression in MAIT cells after 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (K). These data are reflective of 2 independent experiments with n=6 each. *-P<0.05, **-P<0.01, ***-P<0.001.

Journal: bioRxiv

Article Title: Enhancing Mucosal-Associated Invariant T (MAIT) cell function and expansion with human selective serum

doi: 10.1101/2022.10.10.511368

Figure Lengend Snippet: Frequency of MAIT cells after 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (A). Comparison of frequency of CD69+, CD25+, LAG-3+, PD-1+, and TIM-3+ MAIT cells after 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (B-F). Gating strategy and frequency of TNF-α+ and IFN-γ+ MAIT cells following 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (G-I). Frequency of Granzyme-B+ MAIT cells after 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (J). Comparison of MFI of T-bet expression in MAIT cells after 20 hours with or without 10 MOI E. coli stimulation in Phx or FBS-supplemented RPMI (K). These data are reflective of 2 independent experiments with n=6 each. *-P<0.05, **-P<0.01, ***-P<0.001.

Article Snippet: We stained extracellular with fixable viability dye eFluor™ 780 (eBioscience), anti-CD3-BUV395 (BD Biosciences), anti-CD8-BV605 (Biolegend), anti-CD4-BV510 (Biolegend), anti-Vα7.2-PE-Cy7 (Biolegend), anti-LAG-3-BV786 (Biolegend), anti-CD25-BV650 (Biolegend), anti-PD-1-PerCP-Cy-5.5 (Biolegend), anti-CD161-BV605 (Biolegend), anti-CD69-PE-Cy5 (Invitrogen), anti-TCRVδ2-PE-Texas-Red (Biolegend), anti-CD161-APC (Biolegend), and anti-human MR1-5-OP-RU Tetramer (NIH Tetramer Core Facility).

Techniques: Expressing

Tumor-specific recognition and phenotype is largely unchanged between expansion conditions. Epitope-specific recognition of tumor-shared antigens numerated with fluorescent combinatorial encoding of pMHC tetramers. All epitopes were restricted to HLA-A*02:01. Protein expression of CD69 and CD39 in bulk CD8 T cells overlaid by data from each specific population as shown in (A) . Enumeration of tumor-specific ie tetramer double positive CD8 T cells (B) . All populations for each donor are plotted individually. (C) Enumeration of total tumor-specific CD8 T cells i.e. the sum of all individual tetramer double positive CD8 T cells per donor and expansion condition. (D) Stem-like and activated phenotypes for bulk CD8 T cells for each condition of interested described previously . (E) Terminally differentiated phenotypes among tumor-specific CD8 T cells. (F) Terminally differentiated phenotypes among total tumor-specific CD8 T cells. (G) Individual enumeration of each tumor-specific population of interest for each condition with each dot representing individual donors and their responses. ELA, ELAGIGILTV-MART-1. LLF, LLFGLALIEV-MAGEC2. YLE, YLEPGPVTA-gp100. AML, AMLGTHTMEV-gp100. SVY, SVYDFFVWL-TRP-2. ITD, ITDQVPFSV-gp100. KAS, KASEKIFYV-SSX-2. MLA, MLAVISCAV-HERV-K. P values were evaluated using unpaired kruskal-wallis test.

Journal: Frontiers in Immunology

Article Title: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

doi: 10.3389/fimmu.2023.1180997

Figure Lengend Snippet: Tumor-specific recognition and phenotype is largely unchanged between expansion conditions. Epitope-specific recognition of tumor-shared antigens numerated with fluorescent combinatorial encoding of pMHC tetramers. All epitopes were restricted to HLA-A*02:01. Protein expression of CD69 and CD39 in bulk CD8 T cells overlaid by data from each specific population as shown in (A) . Enumeration of tumor-specific ie tetramer double positive CD8 T cells (B) . All populations for each donor are plotted individually. (C) Enumeration of total tumor-specific CD8 T cells i.e. the sum of all individual tetramer double positive CD8 T cells per donor and expansion condition. (D) Stem-like and activated phenotypes for bulk CD8 T cells for each condition of interested described previously . (E) Terminally differentiated phenotypes among tumor-specific CD8 T cells. (F) Terminally differentiated phenotypes among total tumor-specific CD8 T cells. (G) Individual enumeration of each tumor-specific population of interest for each condition with each dot representing individual donors and their responses. ELA, ELAGIGILTV-MART-1. LLF, LLFGLALIEV-MAGEC2. YLE, YLEPGPVTA-gp100. AML, AMLGTHTMEV-gp100. SVY, SVYDFFVWL-TRP-2. ITD, ITDQVPFSV-gp100. KAS, KASEKIFYV-SSX-2. MLA, MLAVISCAV-HERV-K. P values were evaluated using unpaired kruskal-wallis test.

Article Snippet: The fluorochrome-labeled monoclonal antibodies (from BD Biosciences, unless indicated otherwise) BV786 CD3 (563800), BV711 and PE-AF700 CD4 (563033 and MHCD0424, Invitrogen), PerCP-Cy5.5 and QDot605 CD8 (565310 and Q10009, Invitrogen), APC-R700 CD27 (565116), PE-Cy7 CD28 (560684), BV421 CD39 (563679), SB702 CD56 (67-0566-42, Life Technologies), PE-CF594 CD57 (562488), PE-Cy5.5 CD69 (MHCD6918, Invitrogen), BV421 B- and T-lymphocyte attenuator (BTLA, 564802), BV510 CCR7 (353232, Biolegend), BV570 CD45RO (304226, Biolegend), FITC lymphocyte-activation gene 3 (LAG-3, LS-B2237, LS Bioscience), PE-Cy7 PD-1 (561272), BV650 T-cell immunoglobulin and mucin-domain containing-3 (TIM-3, 565564) were used for surface staining.

Techniques: Expressing

Journal: Theranostics

Article Title: HSF1 promotes CD69 + Treg differentiation to inhibit colitis progression

doi: 10.7150/thno.78078

Figure Lengend Snippet: The sequences of primers and siRNAs

Article Snippet: Antibodies including APC-anti-CD4 (Invitrogen, Clone: RM4-5, Catalog: 17-0043-82) or PE-Cy7-anti-CD4 (Invitrogen, Clone: GK1.5, Catalog: 25-0041-82) and PE-anti-CD69 (Invitrogen, Clone: H1.2F3, Catalog: 12-0691-82) or PE-Cy5-anti-CD69 (Invitrogen, Clone: H1.2F3, Catalog: 15-0691-82), PE-anti-Foxp3 (Invitrogen, Clone: FJK-16s, Catalog: 12-5773-82), APC-anti-CD25 (Invitrogen, Clone: PC61.5, Catalog: 17-0251-82), PE-anti-CTLA-4 (Invitrogen, Clone: UC10-4B9, Catalog: 12-1522-82), PE-anti-ICOS (Invitrogen, Clone: C398.41, Catalog: 12-9949-81) or isotype controls(Invitrogen, USA) were used to analyze the phenotype of various Tregs.

Techniques:

CD69 is indispensable to maintain iTregs functio n. ( A ) CD69 fl/fl or Foxp3 YFP-Cre CD69 fl/fl mice were administrated with 2% DSS in drinking water for 9 days (n = 7 for each group). The average body weight is shown as a percentage relative to the initial value. ( B ) The disease activity index is analyzed. The length of the colon ( C ) and histological appearance ( D ) after 9 days of colitis induction. ( E and F ) Naïve CD4 + T cells isolated from CD69 fl/fl or CD4 Cr e CD69 fl/fl mice were cultured for 3 days under Treg-polarization conditions and then analyzed by flow cytometry. Foxp3 YFP-Cre CD69 fl/fl mice after 2 days of DSS administration were intravenously injected with iTregs from CD69 fl/fl and CD4 Cr e CD69 fl/fl mice (n = 7 for each group). The mice's body weight ( G )and the DAI ( H ) were recorded every day. The average body weight is shown as a percentage relative to the initial value. ( I )The average length of the colons. ( J ) Hematoxylin and eosin staining of the colon sections. Scale bar:500 μm (whole colon section) and 100 μm (enlarged insets). ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 compared with the control or the indicated group.

Journal: Theranostics

Article Title: HSF1 promotes CD69 + Treg differentiation to inhibit colitis progression

doi: 10.7150/thno.78078

Figure Lengend Snippet: CD69 is indispensable to maintain iTregs functio n. ( A ) CD69 fl/fl or Foxp3 YFP-Cre CD69 fl/fl mice were administrated with 2% DSS in drinking water for 9 days (n = 7 for each group). The average body weight is shown as a percentage relative to the initial value. ( B ) The disease activity index is analyzed. The length of the colon ( C ) and histological appearance ( D ) after 9 days of colitis induction. ( E and F ) Naïve CD4 + T cells isolated from CD69 fl/fl or CD4 Cr e CD69 fl/fl mice were cultured for 3 days under Treg-polarization conditions and then analyzed by flow cytometry. Foxp3 YFP-Cre CD69 fl/fl mice after 2 days of DSS administration were intravenously injected with iTregs from CD69 fl/fl and CD4 Cr e CD69 fl/fl mice (n = 7 for each group). The mice's body weight ( G )and the DAI ( H ) were recorded every day. The average body weight is shown as a percentage relative to the initial value. ( I )The average length of the colons. ( J ) Hematoxylin and eosin staining of the colon sections. Scale bar:500 μm (whole colon section) and 100 μm (enlarged insets). ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 compared with the control or the indicated group.

Techniques: Activity Assay, Isolation, Cell Culture, Flow Cytometry, Injection, Staining

HSF1 is important for CD69 transcription in CD4 + T cells. ( A ) Schematic of the nucleotide sequence of CD69 promoter, indicating the locations of the putative HSE sites. The potential HSF1 binding sites are shown in boxes. ( B ) HEK293 cells were infected for 48 h with luciferase reporter plasmids as shown on the left as well as a construct that encodes HSF1 or the empty vector, and then, cells were harvested to detect luciferase activity. ( C ) ChIP analysis of HSF1 binding to the CD69 promoter in CD4 + T cells with or without anti-CD3/CD28 mAb stimulation. ( D ) Overall 1×10 6 /mL CD4 + T cells were added to 8 μg polybrene and transfected with control lentivirus or lentivirus-HSF1 at an MOI of 100 for 48 h. CD69 protein levels were determined using flow cytometry. ( E ) CD4 + T cells isolated from HSF1 +/+ and HSF1 +/- mice were stimulated with different doses of anti-CD3/CD28 antibodies, and the mRNA levels of CD69 were detected by qRT-PCR. ( F ) 1 × 10 6 /mL CD4 + T cells were stimulated with or without anti-CD3/CD28 antibodies and treated with HSF1 siRNA for the indicated time. The relative levels of CD69 expression in different groups of CD4 + T cells were determined by qRT-PCR. ( G ) CD4 + T cells isolated from HSF1 +/+ and HSF1 +/- mice were stimulated with or without anti-CD3/CD28 antibodies following the treatment with KRIBB11 for 24 h, and then the expression of CD69 + CD4 + T cell was analyzed by FACS. Representative images of the data expressed as mean ± SD of three independent experiments (n = 7 per group). ns, not significant. * p <0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, as analyzed by ANOVA or Student's t -test.

Journal: Theranostics

Article Title: HSF1 promotes CD69 + Treg differentiation to inhibit colitis progression

doi: 10.7150/thno.78078

Figure Lengend Snippet: HSF1 is important for CD69 transcription in CD4 + T cells. ( A ) Schematic of the nucleotide sequence of CD69 promoter, indicating the locations of the putative HSE sites. The potential HSF1 binding sites are shown in boxes. ( B ) HEK293 cells were infected for 48 h with luciferase reporter plasmids as shown on the left as well as a construct that encodes HSF1 or the empty vector, and then, cells were harvested to detect luciferase activity. ( C ) ChIP analysis of HSF1 binding to the CD69 promoter in CD4 + T cells with or without anti-CD3/CD28 mAb stimulation. ( D ) Overall 1×10 6 /mL CD4 + T cells were added to 8 μg polybrene and transfected with control lentivirus or lentivirus-HSF1 at an MOI of 100 for 48 h. CD69 protein levels were determined using flow cytometry. ( E ) CD4 + T cells isolated from HSF1 +/+ and HSF1 +/- mice were stimulated with different doses of anti-CD3/CD28 antibodies, and the mRNA levels of CD69 were detected by qRT-PCR. ( F ) 1 × 10 6 /mL CD4 + T cells were stimulated with or without anti-CD3/CD28 antibodies and treated with HSF1 siRNA for the indicated time. The relative levels of CD69 expression in different groups of CD4 + T cells were determined by qRT-PCR. ( G ) CD4 + T cells isolated from HSF1 +/+ and HSF1 +/- mice were stimulated with or without anti-CD3/CD28 antibodies following the treatment with KRIBB11 for 24 h, and then the expression of CD69 + CD4 + T cell was analyzed by FACS. Representative images of the data expressed as mean ± SD of three independent experiments (n = 7 per group). ns, not significant. * p <0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, as analyzed by ANOVA or Student's t -test.

Techniques: Sequencing, Binding Assay, Infection, Luciferase, Construct, Plasmid Preparation, Activity Assay, Transfection, Flow Cytometry, Isolation, Quantitative RT-PCR, Expressing

HSF1 is necessary for CD69 + Treg differentiation. Naive CD4 + T cells were cultured in Treg polarization conditions with or without KRIBB11. The frequency of iTreg ( A ) and CD69 + iTreg ( B ) was analyzed by FACS. Induced Tregs were sorted and injected i.v into IBD mice treated with KRIBB11 on day 2. The body weights ( C ) were measured and DAI ( D ) was analyzed daily. ( E ) H&E-stained images of colon sections. Scale bar: 100 μm. ( F-G ) The mice were treated with KRIBB11 and then administration with 2% DSS, body weight and DAI were analyzed daily. ( H ) H&E-stained images of colon sections. Scale bar: 100 μm. Representative images of the data expressed as mean ± SD of three independent experiments (n = 7 per group). ns, not significant. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 as analyzed by ANOVA and Student's t -test.

Journal: Theranostics

Article Title: HSF1 promotes CD69 + Treg differentiation to inhibit colitis progression

doi: 10.7150/thno.78078

Figure Lengend Snippet: HSF1 is necessary for CD69 + Treg differentiation. Naive CD4 + T cells were cultured in Treg polarization conditions with or without KRIBB11. The frequency of iTreg ( A ) and CD69 + iTreg ( B ) was analyzed by FACS. Induced Tregs were sorted and injected i.v into IBD mice treated with KRIBB11 on day 2. The body weights ( C ) were measured and DAI ( D ) was analyzed daily. ( E ) H&E-stained images of colon sections. Scale bar: 100 μm. ( F-G ) The mice were treated with KRIBB11 and then administration with 2% DSS, body weight and DAI were analyzed daily. ( H ) H&E-stained images of colon sections. Scale bar: 100 μm. Representative images of the data expressed as mean ± SD of three independent experiments (n = 7 per group). ns, not significant. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 as analyzed by ANOVA and Student's t -test.

Techniques: Cell Culture, Injection, Staining

MG132 prompts the activation of HSF1 and the expression of CD69. 1 × 10 7 CD4 + T cells were isolated and incubated with 10 µM of MG132 at 37°C for 2 h and then cultured in T lymphocyte culture medium for 24 h. ( A ) All the cells were harvested and protein levels of HSF1 and CD69 were analyzed by western blot. ( B ) The relative levels of CD69 were analyzed by qRT-PCR. ( C ) CD4 + T cells were incubated with MG132 for 2 h and then washed with 1640 RPMI, followed by culture under Treg polarization for 24 h. Cells were then subjected to a ChIP assay using the indicated antibodies. The precipitated DNA was analyzed by quantitative PCR using primer pairs corresponding to the indicated genomic regions. ( D ) CD4 + naive T cells were sorted from HSF1 +/+ o r HSF1 +/- mice and pretreated with MG132 and induced iTregs while HSF1 inhibitor was added at the same time to block HSF1 expression. The flow cytometric analysis of iTregs and CD69 + iTregs expression. Representative images of the data expressed as mean ± SD of three independent experiments. ** p < 0.01, *** p < 0.001, **** p < 0.0001. ns, not significant, as analyzed by ANOVA or Student's t -test.

Journal: Theranostics

Article Title: HSF1 promotes CD69 + Treg differentiation to inhibit colitis progression

doi: 10.7150/thno.78078

Figure Lengend Snippet: MG132 prompts the activation of HSF1 and the expression of CD69. 1 × 10 7 CD4 + T cells were isolated and incubated with 10 µM of MG132 at 37°C for 2 h and then cultured in T lymphocyte culture medium for 24 h. ( A ) All the cells were harvested and protein levels of HSF1 and CD69 were analyzed by western blot. ( B ) The relative levels of CD69 were analyzed by qRT-PCR. ( C ) CD4 + T cells were incubated with MG132 for 2 h and then washed with 1640 RPMI, followed by culture under Treg polarization for 24 h. Cells were then subjected to a ChIP assay using the indicated antibodies. The precipitated DNA was analyzed by quantitative PCR using primer pairs corresponding to the indicated genomic regions. ( D ) CD4 + naive T cells were sorted from HSF1 +/+ o r HSF1 +/- mice and pretreated with MG132 and induced iTregs while HSF1 inhibitor was added at the same time to block HSF1 expression. The flow cytometric analysis of iTregs and CD69 + iTregs expression. Representative images of the data expressed as mean ± SD of three independent experiments. ** p < 0.01, *** p < 0.001, **** p < 0.0001. ns, not significant, as analyzed by ANOVA or Student's t -test.

Techniques: Activation Assay, Expressing, Isolation, Incubation, Cell Culture, Western Blot, Quantitative RT-PCR, Real-time Polymerase Chain Reaction, Blocking Assay

Proteasome inhibitors showed a milder therapeutic effect on IBD. ( A ) Density plots showing CD69 expression in gated CD4 + Foxp3 + cells from freshly isolated spleen, MLN and colonic LPL in mice treated with MG132 and bortezomib. Acute colitis was induced in animals by administering 2% DSS in their drinking water for 9 days. Mice were treated with or without MG132 and bortezomib for 2 days at indicated doses. Changes in body weight ( B ), disease activity index ( C ), and colon length ( D ) and histological sections of inflamed colons ( E ) during the course of DSS treatment in each group of mice. Scale bar:100 μm. ( F ) Survival rates of each group of mice after the initiation of DSS-induced acute colitis were recorded daily (n=10 per group). Representative images of the data expressed as mean ± SD of three independent experiments. * p < 0.01, ** p < 0.01, *** p < 0.001, **** p < 0. 0001.ns, not significant, as analyzed by ANOVA or Student's t -test.

Journal: Theranostics

Article Title: HSF1 promotes CD69 + Treg differentiation to inhibit colitis progression

doi: 10.7150/thno.78078

Figure Lengend Snippet: Proteasome inhibitors showed a milder therapeutic effect on IBD. ( A ) Density plots showing CD69 expression in gated CD4 + Foxp3 + cells from freshly isolated spleen, MLN and colonic LPL in mice treated with MG132 and bortezomib. Acute colitis was induced in animals by administering 2% DSS in their drinking water for 9 days. Mice were treated with or without MG132 and bortezomib for 2 days at indicated doses. Changes in body weight ( B ), disease activity index ( C ), and colon length ( D ) and histological sections of inflamed colons ( E ) during the course of DSS treatment in each group of mice. Scale bar:100 μm. ( F ) Survival rates of each group of mice after the initiation of DSS-induced acute colitis were recorded daily (n=10 per group). Representative images of the data expressed as mean ± SD of three independent experiments. * p < 0.01, ** p < 0.01, *** p < 0.001, **** p < 0. 0001.ns, not significant, as analyzed by ANOVA or Student's t -test.

Techniques: Expressing, Isolation, Activity Assay

Journal: Theranostics

Article Title: HSF1 promotes CD69 + Treg differentiation to inhibit colitis progression

doi: 10.7150/thno.78078

Figure Lengend Snippet: Proteasome inhibitors prompt CD69 expression in vitro . Overall 1 × 10 6 /ml freshly isolated naive CD4 + T cells incubated with or without MG132 for 2 h at 37°C and washed three times with 1640 RPMI. The cells were then stimulated with 2 µg/ml anti-CD3/CD28 antibody, 10ng/ml TGF-β1, and 50 IU/ml of IL-2 for 72 h. ( A ) The levels of IL-10 and TGF-β1 in the supernatants of cultured cells were measured by ELISA. ( B ) Total RNA was extracted from isolated PSI-iTregs and Control-iTregs while the gene expression profile was analyzed using the microarray analysis. The heat map of the gene expression is also shown. ( C and F ) The expression levels of CTLA-4 and ICOS in PSI-iTregs/CD69 + iTregs and Control-iTregs/CD69 + iTregs were analyzed using flow cytometry with indicated antibodies. ( D and G ) 1 × 10 6 /ml of CD4 + CD25 - T cells were labeled with CFSE and co-cultured with PSI-iTregs/CD69 + iTregs and Control-iTregs/CD69 + iTregs at a ratio of 1:1, 1: 2, or 1: 4 in the presence of 1 µl anti-CD3/CD28 coated beads for 3 days. The proliferation of CD4 + T cells was analyzed by flow cytometry. The cells were first gated on living lymphocytes and then on CFSE + T cells (n = 3). ( E ) Naive CD4 + T cells incubated with or without MG132 or Bortezomib then cultured under Treg porlarization condition, the relative frequency of iTregs and CD69 + iTregs was analyzed using FACS (n = 3). Representative images of the data were expressed as mean ± SD of three independent experiments while Student's t -test was used for statistical analysis. * p < 0.01, ** p < 0.01, *** p < 0.001, **** p < 0.0001. ns, not significant.

Techniques: Expressing, In Vitro, Isolation, Incubation, Cell Culture, Enzyme-linked Immunosorbent Assay, Microarray, Flow Cytometry, Labeling

Adoptive transfer of PSI-iTregs attenuated the severity of DSS-induced IBD in mice. IBD was induced by administering DSS in drinking water for 10 days. For the treatment of IBD, 1 × 10 6 PSI-iTregs or Control-iTregs were sorted and intravenously injected into mice on day 2. ( A ) The loss in body weight was recorded daily. Each point represents the average weight data pooled from eight mice ± SD. Control group: the mice fed with normal water; PBS group, the mice were drinking water containing 2% DSS and intravenously treated with PBS on day 2. ( B ) The DAI was evaluated daily. Each point represents the average DAI data pooled from eight mice. ( C ) Appearance and statistical analysis of colon length on day 9. ( D ) Representative H&E staining of the colon mice of different groups. ( E-F ) Weight loss and DAI in mice transferred with PSI-CD69 + iTregs and Control-CD69 + iTregs. ( G-H ) The length of colon and H&E staining of the colon from mice from the different groups. Representative images of the data expressed as the mean ± SD of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.001, ns, not significant. ANOVA or Student's t -test was used to determine the significance.

Journal: Theranostics

Article Title: HSF1 promotes CD69 + Treg differentiation to inhibit colitis progression

doi: 10.7150/thno.78078

Figure Lengend Snippet: Adoptive transfer of PSI-iTregs attenuated the severity of DSS-induced IBD in mice. IBD was induced by administering DSS in drinking water for 10 days. For the treatment of IBD, 1 × 10 6 PSI-iTregs or Control-iTregs were sorted and intravenously injected into mice on day 2. ( A ) The loss in body weight was recorded daily. Each point represents the average weight data pooled from eight mice ± SD. Control group: the mice fed with normal water; PBS group, the mice were drinking water containing 2% DSS and intravenously treated with PBS on day 2. ( B ) The DAI was evaluated daily. Each point represents the average DAI data pooled from eight mice. ( C ) Appearance and statistical analysis of colon length on day 9. ( D ) Representative H&E staining of the colon mice of different groups. ( E-F ) Weight loss and DAI in mice transferred with PSI-CD69 + iTregs and Control-CD69 + iTregs. ( G-H ) The length of colon and H&E staining of the colon from mice from the different groups. Representative images of the data expressed as the mean ± SD of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.001, ns, not significant. ANOVA or Student's t -test was used to determine the significance.

Techniques: Adoptive Transfer Assay, Injection, Staining

Naive cord blood CD4 T cells were transfected with STAT3 specific or control siRNAs in the presence of IL-2. After 48 h, cells were stimulated for 72 hours with plate bound anti-CD3 (5 µg/ml) and soluble anti-CD28 (1 µg/ml) mAbs in the presence of rIL-6 or medium alone before measuring IL-21 production by qRT-PCR (A), membrane expression of ICOS by flow cytometry (A and B), membrane expression of CD69 by flow cytometry and IFN-γ production by ELISA (D). Data are individual results or mean ± SEM of 3 independent experiments on different donors. R.U.: relative units. *p<0.05 as determined by Student's t-test.

Journal: PLoS ONE

Article Title: STAT3 Signaling Induces the Differentiation of Human ICOS + CD4 T Cells Helping B lymphocytes

doi: 10.1371/journal.pone.0071029

Figure Lengend Snippet: Naive cord blood CD4 T cells were transfected with STAT3 specific or control siRNAs in the presence of IL-2. After 48 h, cells were stimulated for 72 hours with plate bound anti-CD3 (5 µg/ml) and soluble anti-CD28 (1 µg/ml) mAbs in the presence of rIL-6 or medium alone before measuring IL-21 production by qRT-PCR (A), membrane expression of ICOS by flow cytometry (A and B), membrane expression of CD69 by flow cytometry and IFN-γ production by ELISA (D). Data are individual results or mean ± SEM of 3 independent experiments on different donors. R.U.: relative units. *p<0.05 as determined by Student's t-test.

Article Snippet: Cell phenotype was characterized by surface staining with the following antibodies: ICOS FITC (eBioscience), CD69 PE-Cy5 (BD Biosciences), CXCR5 AF 488 (BD biosciences).

Techniques: Transfection, Quantitative RT-PCR, Expressing, Flow Cytometry, Enzyme-linked Immunosorbent Assay

Journal: Cell reports

Article Title: Dynamic spectrum of ectopic lymphoid B cell activation and hypermutation in the RA synovium characterized by NR4A nuclear receptor expression

doi: 10.1016/j.celrep.2022.110766

Figure Lengend Snippet:

Article Snippet: PE-cy5 mouse anti-human CD69 , BD Biosciences , Cat#555532;RRID: AB_395917.

Techniques: Staining, RNA Sequencing Assay, Sequencing, Software

Review

Structured Review

Images

Similar Products

Image Search Results